News

AddToAny

Google+ Facebook Twitter Twitter

New cancer-driving mutation

Scientists have discovered a novel cancer-driving mutation in the vast non-coding regions of the human cancer genome, also known as the “dark matter” of human cancer DNA.

The mutation, as described in two related studies, represents a new potential therapeutic target for several types of cancer including brain, liver and blood. 

This could be used to develop treatments for patients with these difficult-to-treat diseases.

Lincoln Stein, study co-lead, said: “Non-coding DNA, which makes up 98% of the genome, is notoriously difficult to study and is often overlooked since it does not code for proteins. 

“By carefully analysing these regions, we discovered a change in one letter of the DNA code that can drive multiple types of cancer. In turn, we’ve found a new cancer mechanism that we can target to tackle the disease.”

The research group discovered that the mutation, termed “U1-snRNA”, could disrupt normal RNA splicing and thereby alter the transcription of cancer-driving genes. 

These molecular mechanisms represent new ways to treat cancers carrying the mutation. One of the potential treatment approaches includes repurposing existing drug.


Image credit | iStock

Related Articles

My lab: diagnostic cytopathology and molecular

Specialist Biomedical Scientist Beth Carroll gives a guided tour of her laboratory in Cornwall.

Life in cytology (without cervical screening)

Consultant Biomedical Scientist Tracey Stevenson discusses developing a diagnostic cytology service after her previous laboratory was unsuccessful in bidding for cervical screening programme work.

Diffuse optics for diagnosticsDiffuse optics for diagnostics

Among the optics-based tools used in diagnostics, diffuse optics (DO) is rapidly emerging as one of the most attractive technologies.

Clinical andrology: overcoming barriers, improving outcomes

Clinical Scientist and Andrology Service Lead Stuart Long on the impact that taking on a patient-facing role can have.

Top